Stock Research: Kissei Pharmaceutical

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Kissei Pharmaceutical

TYO:4547 JP3240600001
60
  • Value
    63
  • Growth
    54
  • Safety
    Safety
    96
  • Combined
    88
  • Sentiment
    39
  • 360° View
    360° View
    60
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

KISSEI PHARMACEUTICAL CO.,LTD. is a Japan-based company primarily engaged in the manufacture and sale of pharmaceutical products. Its main businesses include the collection and analysis of medicine development information, manufacture and sale of medicines, purchase and sale of related materials, system development, construction contract work, facility management, and insurance agency business. It primarily operates in Japan. In the last fiscal year, the company had 1778 employees, a market cap of $1308 million, profits of $294 million, and revenue of $589 million.

more
Index
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
63 76 86 85
Growth
54 51 35 19
Safety
Safety
96 92 65 94
Sentiment
39 32 10 44
360° View
360° View
60 81 45 83
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
38 17 35 78
Opinions Change
85 28 6 96
Pro Holdings
n/a 80 44 12
Market Pulse
4 44 7 3
Sentiment
39 32 10 44
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
63 76 86 85
Growth
54 51 35 19
Safety Safety
96 92 65 94
Combined
88 98 77 78
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
42 48 55 72
Price vs. Earnings (P/E)
50 56 86 47
Price vs. Book (P/B)
86 95 78 100
Dividend Yield
76 63 78 88
Value
63 76 86 85
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
9 11 33 67
Profit Growth
55 32 42 11
Capital Growth
66 82 7 1
Stock Returns
59 78 87 71
Growth
54 51 35 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
91 91 85 82
Refinancing
75 83 89 91
Liquidity
94 76 4 61
Safety Safety
96 92 65 94

Similar Stocks

Discover high‑ranked alternatives to Kissei Pharmaceutical and broaden your portfolio horizons.

BML

TYO:4694
Country: Japan
Industry: Health Care Services
Size: Medium
Full Stock Analysis

Nishi-Nippon Railroad

TYO:9031
Country: Japan
Industry: Railroads
Size: Medium
Full Stock Analysis

Kinden

TYO:1944
Country: Japan
Industry: Construction & Engineering
Size: Large
Full Stock Analysis

Subaru

TYO:7270
Country: Japan
Industry: Automobile Manufacturers
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This stock is a good value with safe financing, but has low growth and negative sentiment. It is a good option for a cautious value investor looking for stability but who can tolerate low momentum and skeptical professional opinion.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: